Fallond Portfolio: PODD out

Insulet Corp (PODD) dipped into the low $22s before it staged its post-morning rally. The drop was enough to hit the stop to close the 500 share position for a -$755 (-6.4%) loss.



Three positions remain in the portfolio as market exposure is reduced following the failed breakouts in large caps and the lagging performance of small caps.

Collective2

Fallond Portfolio: LWAY out

Lifeway Foods (LWAY) was the best play of the summer for the portfolio, but unfortunately the stock undercut what I considered to be support, and the position was stopped out for a reduced profit (an alternative support would be the lows of the big white candlestick i.e. a loss of $17). The 700 share position finished with a +$3,052 (+33.5%) profit. The gains were enough to give a net positive return for August (+2.5% per trade)

Collective2

Fallond portfolio: FOLD, ALLI, and CKSW out

A busy day for the Collective2 portfolio. One play which I forgot to publish last week was the brief 1-day fling for Genomic Health (GHDX). The 500 share lot closed for a -$495 (-4.8%) loss which was a frustrating loss as I looked to increase equity exposure. The three hits for today produced mixed results:

Allion Healthcare (ALLI) did not release any news but the stock jumped 5% on heavier volume in the absence of news. Unfortunately, the stop was hit on the initial break of support. The 1,400 share play closed for a +$252 (+2.8%) profit - but today's exit was a fakeout.



The second stock, ClickSoftware Technologies (CKSW) is set to release earnings on October 31st. But a second day of gains saw the stock tag resistance (and therefore hit its target), for a +27% gain, or a +$2,780 gain on a 2,000 share lot.



Finally, there was a loss for Amicus Therapeutics (FOLD). Although there was no news released on the day, the stock fell back to undercut what looked to be reasonable support. The stock was a morning buy but an afternoon sell. The 500 share position closed for a -$305 (-3.4%) loss.

Five positions remain in the portfolio.

Collective2

Fallond Portfolio: UXG out

The market breakout has turned negative on gold stocks. The stock was entered on the premise of a bounce off the 50-day MA to go test (and break) $7.00 resistance. U.S. Gold (UXG) cut below $6.25 support and its 50-day MA, to run into its stop and close the 1,300 share position for a -$403 loss (-4.92%).



Collective2